Diabetes Clinical Trials in Fort Lauderdale

View 120 new treatments for Diabetes in Fort Lauderdale, FL, and other areas near me, such as Davie, Hollywood, Miramar and Pembroke Pines. Every day, Power helps hundreds of diabetes patients connect with leading medical research.
View 119 trials in Fort Lauderdale
Filter (119)

Islet Transplantation for Type 1 Diabetes

Research Clinic, Miami + 2 more

The intervention in this trial is intraocular islet transplantation. A single dose of 1000 - 3000 Islet Equivalents (IEQ)/kg recipient body weight (BW) will be infused into the anterior chamber of the eye through a self-sealing incision in the peripheral cornea. The procedure is projected to take approximately 20-30 minutes. Subject will remain flat on their back for 1 - 3 hours after islet infusion to maximize adhesion of the islets to the iris.Show More

Verified

Recruiting

No Placebo Trial

Phase 1 & 2
Est. 6 - 12 Weeks
Midhat Abdulreda, Ph.D.
Principal Investigator

Derm-Maxx for Diabetic Foot

Research Clinic, Miami Lakes + 1 more

This randomized controlled study evaluates the adjuvant use of Derm-Maxx in patients with diabetic foot ulcers

Verified

Waitlist

No Placebo Trial

N/A
Est. 5 - 8 Weeks
Windy Cole, DPM
Principal Investigator

RESET Liner for Type-2 Diabetes and Obesity

Morphic Clinic, Miami + 2 more

This trial is testing the RESET System, a device placed in the stomach, to help people with Type 2 Diabetes and Obesity who haven't controlled their blood sugar well with current medications. The device works by reducing food absorption, aiding in better blood sugar control and weight loss. The RESET System has been shown to help with weight loss and better blood sugar control in patients with type 2 diabetes.Show More

Verified

Recruiting
N/A
Est. 5 - 8 Weeks
Christopher C Thompson, MD
Principal Investigator

Amnio Products for Diabetic Foot Ulcers and Venous Leg Ulcers

Stability Clinic, Miami + 1 more

This is a multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot and venous leg ulcers.Show More

Verified

Recruiting

No Placebo Trial

N/A
Est. 3 - 12 Weeks
Unregistered Study Lead
Research Team

Biomarker Study for Cancer

Audubon Bioscience Clinic, West Palm Beach + 1 more

Study purpose: to explore the entire spectrum of proteomic and genomic changes (amongst others) involved in diseases and in healthy/control populations. The Study is designed to discover biomarkers, develop and validate diagnostic assays, instruments and therapeutics as well as other medical research. Specifically, researchers may analyze proteins, RNA, DNA copy number changes, including large and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both diseased tissue and case-matched germline DNA from Subjects.Show More

Verified

Waitlist

No Placebo Trial

N/A
Est. 4 - 6 Weeks
Unregistered Study Lead
Research Team

Metformin for Prediabetes

Research Clinic, Miami + 1 more

This trial is testing whether metformin can lower the risk of death, heart attacks, and strokes in people with pre-diabetes and heart or blood vessel issues. Metformin is a drug that helps control blood sugar levels and has been used to treat type 2 diabetes mellitus for more than 60 years. The study involves patients who have pre-diabetes and existing heart or blood vessel problems, aiming to see if metformin can provide additional health benefits.Show More
Recruiting
Phase 4
Est. 3 - 6 Weeks
Gregory G. Schwartz, PhD MD
Study Chair

Tirzepatide for Type 2 Diabetes

Eli Lilly Clinic, Boca Raton + 3 more

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing treatment options when treatment is initiated early.Show More
Waitlist

No Placebo Trial

Phase 4
Est. 3 - 12 Weeks
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director

Rifampin for Osteomyelitis in Diabetics

Research Clinic, Miami + 1 more

The purpose of this research study is to determine if rifampin, an antibiotic (a medicine that treats infections), is effective in treating osteomyelitis (infection of the bone) of the foot in diabetic patients. Despite use of powerful antibiotics prescribed over a long period of time, many diabetic patients remain at a high risk for needing an amputation of part of the foot or lower leg because the osteomyelitis is not cured. Some small research studies have shown that addition of rifampin to other antibiotics is effective in treating osteomyelitis in both diabetics and non-diabetics. However, because few diabetics with osteomyelitis have been studied, there is no definite proof that it is better than the usual treatments for diabetic patients. If this study finds that adding rifampin to the usual antibiotics prescribed for osteomyelitis reduces the risk for amputations, doctors will be able to more effectively treat many Veteran patients with this serious infection. Improving treatment outcomes is an important healthcare goal of the VA.Show More
Recruiting
Phase 4
Est. 3 - 6 Weeks
Mary T Bessesen, MD
Study Chair

Faricimab for Diabetic Macular Edema

Genentech Clinic, Miami + 2 more

This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, Hispanic/Latino American, or Native American/Alaska Native/Native Hawaiian or other Pacific Islander; in addition, a cohort of Asian Indian participants will be enrolled in India.Show More
Recruiting

No Placebo Trial

Phase 4
Est. 6 - 12 Weeks
Clinical Trials
Study Director

Naltrexone + Bupropion for Obesity

Currax Clinic, Miami + 8 more

This trial studies the effects of a medication combination (naltrexone and bupropion) on heart health. It targets patients to see if this treatment increases the risk of major heart problems. The study also includes advice on diet and exercise. Naltrexone and bupropion have been used in combination for weight loss, but they have been associated with various adverse effects, including neuropsychiatric disorders and cardiovascular risks.Show More
Recruiting
Phase 4
Est. 5 - 8 Weeks
Unregistered Study Lead
Research Team
Page 1 of 12

Frequently Asked Questions

How much do diabetes clinical trials pay?

Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.

Do I need to be insured to participate in a medical study?

Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

How do diabetes clinical trials work?

After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across diabetes trials in Fort Lauderdale, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for diabetes patients is 6 Months.

What does the "phase" of a clinical trial mean?

The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.

Where in Fort Lauderdale is research being conducted for diabetes?

Prominent hospitals in Fort Lauderdale conducting diabetes clinical trials include Broward Health Medical Center. Trials are also taking place in the northern and central areas of the city, with approximately 6 ongoing as of 2024.

What promising new drugs are being tested?

In Fort Lauderdale, diabetes research is exploring treatments like Continuous Glucose Monitoring systems and Monoclonal Antibodies. Notable specific interventions include the Eversense CGM System, Inclisiran sodium, and Ranibizumab.